Down-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion

Virology

Volumn 405, Issue 2, 2010, Pages 457-463

  Jarosinski, Keith W ^a   Hunt, Henry D ^b   Osterrieder, Nikolaus ^a,c  

^a Department of Obstetrics Gynecology   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Chicken; Genetic resistance; Major histocompatibility complex down regulation; Marek's disease virus; Pathogenesis

Indexed keywords

GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UL49.5 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CHICKEN; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EMBRYO; FIBROBLAST; HAPLOTYPE; MARDIVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; B-LYMPHOCYTES; CELL LINE; CHICKENS; DOWN-REGULATION; FIBROBLASTS; GENES, MHC CLASS I; HAPLOTYPES; HERPESVIRUS 2, GALLID; HISTOCOMPATIBILITY ANTIGENS CLASS I; MAREK DISEASE; POULTRY DISEASES; VIRAL PROTEINS; VIRULENCE;

GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 77955658459     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.041     Document Type: Article

References (20)

1. Calnek B.W. Pathogenesis of Marek's disease virus infection. Marek's disease 2001, 25-55. Springer, Berlin, Germany. K. Hirai (Ed.).
2. Cole R.K. Studies on genetic resistance to Mareks disease. Avian Dis. 1968, 12:9-28.
3. Dorange F., Tischer B.K., Vautherot J.F., Osterrieder N. Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J. Virol. 2002, 76:1959-1970.
4. Eisfeld A.J., Yee M.B., Erazo A., Abendroth A., Kinchington P.R. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms. J. Virol. 2007, 81:9034-9049.
5. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P.M., Tampe R., Peterson P.A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375:415-418.
6. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411-415.
7. Hunt H.D., Lupiani B., Miller M.M., Gimeno I., Lee L.F., Parcells M.S. Marek's disease virus down-regulates surface expression of MHC (B Complex) Class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology 2001, 282:198-205.
8. Jarosinski K.W., Osterrieder N., Nair V.K., Schat K.A. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J. Virol. 2005, 79:11647-11659.
9. Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., Nair V.K., Osterrieder N. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J. Virol. 2007, 81:10575-10587.
10. Koppers-Lalic D., Rychlowski M., van Leeuwen D., Rijsewijk F.A.M., Ressing M.E., Neefjes J.J., Bienkowska-Szewczyk K., Wiertz E.J.H.J. Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells. Arch. Virol. 2003, 148:2023-2037.
11. Koppers-Lalic D., Reits E.A., Ressing M.E., Lipinska A.D., Abele R., Koch J., Marcondes R.M., Admiraal P., van Leeuwen D., Bienkowska-Szewczyk K., Mettenleiter T.C., Rijsewijk F.A., Tampe R., Neefjes J., Wiertz E.J. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl Acad. Sci. USA 2005, 102:5144-5149.
12. Ogura H., Fujiwara T. Establishment and characterization of A virus-free chick cell-line. Acta Med. Okayama 1987, 41:141-143.
13. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 2004, 78:13376-13380.
14. Pinto A.K., Munks M.W., Koszinowski U.H., Hill A.B. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J. Immunol. 2006, 177:3225-3234.
15. Schat K.A., Purchase H.G. Cell-culture methods. A Laboratory Manual for the Isolation and Identification of Avian Pathogens 1998, 223-234. American Association of Avian Pathologists, Kennett Square, PA. D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. Reed (Eds.).
16. Schumacher D., Tischer B.K., Fuchs W., Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 2000, 74:11088-11098.
17. Spatz S.J., Zhao Y., Petherbridge L., Smith L.P., Baigent S.J., Nair V. Comparative sequence analysis of a highly oncogenic but horizontal spread-deficient clone of Marek's disease virus. Virus Genes 2007, 35:753-766.
18. Spatz S.J., Rue C., Schumacher D., Osterrieder N. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain. Virus Genes 2008, 37:69-80.
19. Tischer B.K., Schumacher D., Messerle M., Wagner M., Osterrieder N. The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Gen. Virol. 2002, 83:997-1003.
20. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F. The genome of a very virulent Marek's disease virus. J. Virol. 2000, 74:7980-7988.